Skip navigation

Boehringer Ingelheim Partnering Day

14:00 – 18:00

The King’s Fund, 11 – 13 Cavendish Square, Marylebone, London W1G 0AN
26 April 2018

Boehringer Ingelheim knows what it takes to be innovative and entrepreneurial. From the small factory in 1885 to today’s multi-billion-dollar global pharmaceutical organisation, it knows how important it is to nurture and develop emerging science and technology businesses. 

Boehringer Ingelheim’s track record of bringing innovative medicines to patients starts with new ideas and new science. And collaborations with external partners play an essential role in helping the Company to deliver an innovation-led portfolio. Join Boehringer Ingelheim at its partnering day to discover how you can learn from each other and work together to develop the next generation of medicines.

Its research and partnering leadership teams will be available throughout the day for one-to-one meetings and at this networking reception in the evening:

Discover its approach to research and partnering
Meet its research and partnering leadership teams 
Learn more about  research and partnering interests

how its Corporate Venture Fund drives innovation through its strategic investment in early-stage science and technology.

If you are interested in discussing potential opportunities for partnering you can apply for a one-to-one with meeting with the Boehringer Ingelheim team. You can also register to attend the event and networking reception. 


08:00 - One-to-one Partnering Meetings

13:00 - Networking Lunch

14:00 - Registration for Plenary Sessions

14:30 - Company Presentations
Speakers include:

  • Dr. Clive R. Wood, Head of Discovery Research
  • Dr. Paola Casarosa, Head of Business Development and Licensing
    Dr. Detlev Mennerich, Director and Investment Manager of the Boehringer Ingelheim Venture Fund

15:30 - Panel Discussion: Collaborative Science and Partnering with Boehringer Ingelheim
Panelists include:
Dr. Paul Adam, Head of Cancer Immunology Target Discovery, Boehringer Ingelheim
Dr. Klaus Mendla, Global Head of CNS BD&L, Boehringer Ingelheim
Dr. Charles Large, CEO, Autifony
Dr. Christian Rohlff, CEO Oxford Biotherapeutics
Dr. Paul Ashley, Head of Licensing & Ventures - Life Science, Oxford University Innovation

16:45 - Networking Reception

19.00 - end

To learn more about their partnering interests please visit:
You can also virtually meet the Business Development and Licensing team in this video.  

And learn more about their approach to partnering in this video.

This event is on invitation only. If you would like to express an interest in attending, please email Aline

Title: Boehringer Ingelheim Partnering Day
Start: 2018-04-26 14:00:00Z
End: 2018-04-26 18:00:00Z